Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Robust, atlas-free, automatic segmentation of brain MRI in health and disease.

Selvaganesan K, Whitehead E, DeAlwis PM, Schindler MK, Inati S, Saad ZS, Ohayon JE, Cortese ICM, Smith B, Steven Jacobson, Nath A, Reich DS, Inati S, Nair G.

Heliyon. 2019 Feb 18;5(2):e01226. doi: 10.1016/j.heliyon.2019.e01226. eCollection 2019 Feb.

2.

Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement.

Bhargava P, Wicken C, Smith MD, Strowd RE, Cortese I, Reich DS, Calabresi PA, Mowry EM.

Mult Scler Relat Disord. 2019 Feb 11;30:136-140. doi: 10.1016/j.msard.2019.02.013. [Epub ahead of print]

PMID:
30771580
3.

[Surveillance of Sensitivity to Penicillin in streptococcus Agalactiae recovered from pregnant women between 35-37 weeks of gestation].

Müller Velázquez L, Bobadilla F, Novosak M, Cortese I, Laczeski M.

Rev Fac Cien Med Univ Nac Cordoba. 2017 Dec 21;74(4):320-324. Spanish.

PMID:
29902137
4.

Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases.

Enose-Akahata Y, Azodi S, Smith BR, Billioux BJ, Vellucci A, Ngouth N, Tanaka Y, Ohayon J, Cortese I, Nath A, Jacobson S.

PLoS Pathog. 2018 Apr 30;14(4):e1007042. doi: 10.1371/journal.ppat.1007042. eCollection 2018 Apr.

5.

Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.

Beck ES, Sati P, Sethi V, Kober T, Dewey B, Bhargava P, Nair G, Cortese IC, Reich DS.

AJNR Am J Neuroradiol. 2018 Feb 8. doi: 10.3174/ajnr.A5534. [Epub ahead of print]

PMID:
29439120
6.

Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).

Azodi S, Nair G, Enose-Akahata Y, Charlip E, Vellucci A, Cortese I, Dwyer J, Billioux BJ, Thomas C, Ohayon J, Reich DS, Jacobson S.

Ann Neurol. 2017 Nov;82(5):719-728. doi: 10.1002/ana.25072. Epub 2017 Nov 8.

PMID:
29024167
7.

Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent N-acetylaspartate.

Wood ET, Ercan E, Sati P, Cortese ICM, Ronen I, Reich DS.

Neuroimage Clin. 2017 Jun 22;15:780-788. doi: 10.1016/j.nicl.2017.06.028. eCollection 2017.

8.

Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis.

Tanigawa M, Stein J, Park J, Kosa P, Cortese I, Bielekova B.

Mult Scler J Exp Transl Clin. 2017 Jan 1;3(1):2055217316688930. doi: 10.1177/2055217316688930. eCollection 2017 Jan-Mar.

9.

Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis.

Foley RW, Tagg NT, Schindler MK, Fenton KM, Reich DS, Cortese I, Mowry EM.

Mult Scler. 2017 Sep;23(10):1424-1427. doi: 10.1177/1352458517702533. Epub 2017 Jun 22.

10.

Cultivating the Multiple Sclerosis Workforce of the Future.

DeLuca GC, Buckle G, Cortese I, Graves JS, Halper J, Newsome SD, Sicotte N, Ford CC; FCMSC MS Mentorship Forum Participants.

Int J MS Care. 2017 May-Jun;19(3):123-130. doi: 10.7224/1537-2073.2015-068.

11.

Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.

Absinta M, Cortese IC, Vuolo L, Nair G, de Alwis MP, Ohayon J, Meani A, Martinelli V, Scotti R, Falini A, Smith BR, Nath A, Jacobson S, Filippi M, Reich DS.

Neurology. 2017 Apr 11;88(15):1439-1444. doi: 10.1212/WNL.0000000000003820. Epub 2017 Mar 10.

12.

Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members.

Xia Z, Steele SU, Bakshi A, Clarkson SR, White CC, Schindler MK, Nair G, Dewey BE, Price LR, Ohayon J, Chibnik LB, Cortese IC, De Jager PL, Reich DS.

JAMA Neurol. 2017 Mar 1;74(3):293-300. doi: 10.1001/jamaneurol.2016.5056.

13.

Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment.

Kosa P, Ghazali D, Tanigawa M, Barbour C, Cortese I, Kelley W, Snyder B, Ohayon J, Fenton K, Lehky T, Wu T, Greenwood M, Nair G, Bielekova B.

Front Neurol. 2016 Aug 15;7:131. doi: 10.3389/fneur.2016.00131. eCollection 2016.

14.

Slowly eroding lesions in multiple sclerosis.

Sethi V, Nair G, Absinta M, Sati P, Venkataraman A, Ohayon J, Wu T, Yang K, Shea C, Dewey BE, Cortese IC, Reich DS.

Mult Scler. 2017 Mar;23(3):464-472. doi: 10.1177/1352458516655403. Epub 2016 Jul 11.

15.

Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.

Absinta M, Sati P, Schindler M, Leibovitch EC, Ohayon J, Wu T, Meani A, Filippi M, Jacobson S, Cortese IC, Reich DS.

J Clin Invest. 2016 Jul 1;126(7):2597-609. doi: 10.1172/JCI86198. Epub 2016 Jun 6.

16.

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.

Komori M, Lin YC, Cortese I, Blake A, Ohayon J, Cherup J, Maric D, Kosa P, Wu T, Bielekova B.

Ann Clin Transl Neurol. 2016 Feb 1;3(3):166-79. doi: 10.1002/acn3.293. eCollection 2016 Mar.

17.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

18.

Cutaneous adverse events in multiple sclerosis patients treated with daclizumab.

Cortese I, Ohayon J, Fenton K, Lee CC, Raffeld M, Cowen EW, DiGiovanna JJ, Bielekova B.

Neurology. 2016 Mar 1;86(9):847-55. doi: 10.1212/WNL.0000000000002417. Epub 2016 Feb 3.

19.

Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.

George IC, Sati P, Absinta M, Cortese IC, Sweeney EM, Shea CD, Reich DS.

Mult Scler. 2016 Oct;22(12):1578-1586. Epub 2016 Jan 14.

20.

Novel composite MRI scale correlates highly with disability in multiple sclerosis patients.

Kosa P, Komori M, Waters R, Wu T, Cortese I, Ohayon J, Fenton K, Cherup J, Gedeon T, Bielekova B.

Mult Scler Relat Disord. 2015 Nov;4(6):526-35. doi: 10.1016/j.msard.2015.08.009. Epub 2015 Aug 28.

21.

Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk.

Xia Z, White CC, Owen EK, Von Korff A, Clarkson SR, McCabe CA, Cimpean M, Winn PA, Hoesing A, Steele SU, Cortese IC, Chitnis T, Weiner HL, Reich DS, Chibnik LB, De Jager PL.

Ann Neurol. 2016 Feb;79(2):178-89. doi: 10.1002/ana.24560. Epub 2015 Dec 9.

22.

Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study.

Martin F, Inoue E, Cortese IC, de Almeida Kruschewsky R, Adonis A, Grassi MF, Galvão-Castro B, Jacobson S, Yamano Y, Taylor GP, Bland M.

Pilot Feasibility Stud. 2015 Oct 23;1:35. eCollection 2015.

23.

Direct MRI detection of impending plaque development in multiple sclerosis.

Absinta M, Nair G, Sati P, Cortese IC, Filippi M, Reich DS.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 3;2(5):e145. doi: 10.1212/NXI.0000000000000145. eCollection 2015 Oct.

24.

Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.

Absinta M, Vuolo L, Rao A, Nair G, Sati P, Cortese IC, Ohayon J, Fenton K, Reyes-Mantilla MI, Maric D, Calabresi PA, Butman JA, Pardo CA, Reich DS.

Neurology. 2015 Jul 7;85(1):18-28. doi: 10.1212/WNL.0000000000001587. Epub 2015 Apr 17.

25.

Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging.

Reich DS, White R, Cortese IC, Vuolo L, Shea CD, Collins TL, Petkau J.

Mult Scler. 2015 Nov;21(13):1693-704. doi: 10.1177/1352458515569098. Epub 2015 Feb 6.

26.

Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.

Gao KC, Nair G, Cortese IC, Koretsky A, Reich DS.

Neuroimage. 2014 Oct 15;100:370-8. doi: 10.1016/j.neuroimage.2014.06.014. Epub 2014 Jun 16.

27.

Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations.

Brunetto GS, Massoud R, Leibovitch EC, Caruso B, Johnson K, Ohayon J, Fenton K, Cortese I, Jacobson S.

J Neurovirol. 2014 Aug;20(4):341-51. doi: 10.1007/s13365-014-0249-3. Epub 2014 Apr 30.

28.

Daclizumab-induced adverse events in multiple organ systems in multiple sclerosis.

Oh J, Saidha S, Cortese I, Ohayon J, Bielekova B, Calabresi PA, Newsome SD.

Neurology. 2014 Mar 18;82(11):984-8. doi: 10.1212/WNL.0000000000000222. Epub 2014 Feb 14.

29.

Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.

Han S, Lin YC, Wu T, Salgado AD, Mexhitaj I, Wuest SC, Romm E, Ohayon J, Goldbach-Mansky R, Vanderver A, Marques A, Toro C, Williamson P, Cortese I, Bielekova B.

J Immunol. 2014 Mar 15;192(6):2551-63. doi: 10.4049/jimmunol.1302884. Epub 2014 Feb 7.

30.

Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling.

Jones BC, Nair G, Shea CD, Crainiceanu CM, Cortese IC, Reich DS.

Neuroimage Clin. 2013 Aug 13;3:171-9. doi: 10.1016/j.nicl.2013.08.001. eCollection 2013.

31.

Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process.

Absinta M, Sati P, Gaitán MI, Maggi P, Cortese IC, Filippi M, Reich DS.

Ann Neurol. 2013 Nov;74(5):669-78. doi: 10.1002/ana.23959. Epub 2013 Sep 16.

32.

Therapeutic plasma exchange in neurology: 2012.

Cortese I, Cornblath DR.

J Clin Apher. 2013 Feb;28(1):16-9. doi: 10.1002/jca.21266. Review.

33.

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A.

Neurology. 2011 Jan 18;76(3):294-300. doi: 10.1212/WNL.0b013e318207b1f6. Review.

34.

Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neurotoxicity.

Cheong R, Wilson RK, Cortese IC, Newman-Toker DE.

Subst Abus. 2006 Dec;27(4):63-7. Review.

PMID:
17347127
35.

Case 11: a young woman with ring-enhancing brain lesions.

Cortese I, Nath A.

MedGenMed. 2006 Jan 5;8(1):3. No abstract available.

36.

Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon.

Nath A, Venkataramana A, Reich DS, Cortese I, Major EO.

Neurology. 2006 Jan 10;66(1):149-50. No abstract available.

PMID:
16401874
37.

CD4+CD28- costimulation-independent T cells in multiple sclerosis.

Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R.

J Clin Invest. 2001 Oct;108(8):1185-94.

38.

Dendritic cells signal T cells in the absence of exogenous antigen.

Kondo T, Cortese I, Markovic-Plese S, Wandinger KP, Carter C, Brown M, Leitman S, Martin R.

Nat Immunol. 2001 Oct;2(10):932-8.

PMID:
11561182
39.

Cross-reactive phage-displayed mimotopes lead to the discovery of mimicry between HSV-1 and a brain-specific protein.

Cortese I, Capone S, Luchetti S, Cortese R, Nicosia A.

J Neuroimmunol. 2001 Feb 1;113(1):119-28.

PMID:
11137583
40.

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, McFarland HF, Martin R.

Nat Med. 2000 Oct;6(10):1167-75. Erratum in: Nat Med 2000 Dec;6(12):1412.

PMID:
11017150
41.

Minimal peptide length requirements for CD4(+) T cell clones--implications for molecular mimicry and T cell survival.

Hemmer B, Kondo T, Gran B, Pinilla C, Cortese I, Pascal J, Tzou A, McFarland HF, Houghten R, Martin R.

Int Immunol. 2000 Mar;12(3):375-83.

PMID:
10700472
42.

Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease.

Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B, Straus SE, McFarland HF, Houghten R, Simon R, Pinilla C, Martin R.

Nat Med. 1999 Dec;5(12):1375-82.

PMID:
10581079
43.

Effects of early postnatal exposure to low concentrations of carbon monoxide on cognitive functions in rats.

Tattoli M, Carratù MR, Cassano T, Cortese I, Di Giovanni V, Elia G, Renna G, Cagiano R.

Pharmacol Res. 1999 Sep;40(3):271-4.

PMID:
10479472
44.

CSF-enriched antibodies do not share specificities among MS patients.

Cortese I, Capone S, Luchetti S, Grimaldi LM, Nicosia A, Cortese R.

Mult Scler. 1998 Jun;4(3):118-23.

PMID:
9762658
45.

Identification of peptides binding to IgG in the CSF of multiple sclerosis patients.

Cortese I, Capone S, Tafi R, Grimaldi LM, Nicosia A, Cortese R.

Mult Scler. 1998 Feb;4(1):31-6.

PMID:
9532590
46.

Selection of biologically active peptides by phage display of random peptide libraries.

Cortese R, Monaci P, Luzzago A, Santini C, Bartoli F, Cortese I, Fortugno P, Galfrè G, Nicosia A, Felici F.

Curr Opin Biotechnol. 1996 Dec;7(6):616-21. Review.

PMID:
8939640
47.

Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries.

Cortese I, Tafi R, Grimaldi LM, Martino G, Nicosia A, Cortese R.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11063-7.

48.

Ultrasonic vocalization during the acquisition of an active avoidance schedule in rats: effects of diazepam.

De Salvia MA, Cagiano R, Cortese I, Lacomba C, Renna G, Siro Brigiani G, Cuomo V.

Pharmacol Res. 1990 Sep-Oct;22 Suppl 1:65-6. No abstract available.

PMID:
2284251
49.

[Therapy of non-ulcer dyspepsia].

Cortese I, Maselli MA.

Clin Ter. 1990 Apr 30;133(2):103-7. Review. Italian.

PMID:
2140745
50.

Behavioural changes in offspring of rats exposed to diazepam during gestation.

De Salvia MA, Cagiano R, Cortese I, Renna G, Tattoli M, Tortella E, Cuomo V.

Pharmacol Res. 1989 Nov-Dec;21 Suppl 1:27-8. No abstract available.

PMID:
2633177

Supplemental Content

Loading ...
Support Center